The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism
Tarih
2009Yazar
Balat, Ozcan
PENÇE, Sadrettin
AKÇALI, CENK
ÇİÇEK, HÜLYA
DİKENSOY, EBRU
Üst veri
Tüm öğe kaydını gösterÖzet
Flutamide is an effective drug in treatment of hirsutism. Hepatotoxicity occasionally may occur with therapeutic doses (750-1500 mg/day), 3 months after initiation of treatment. Monitoring of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels is recommended to obviate serious hepatotoxicity.
Koleksiyonlar
- Makale [92796]